These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12925383)

  • 41. Hemostatic management during oral surgery in patients with a left-ventricular assist system undergoing high-level anticoagulant therapy: efficacy of low molecular weight heparin.
    Morimoto Y; Niwa H; Hanatani A; Nakatani T
    J Oral Maxillofac Surg; 2008 Mar; 66(3):568-71. PubMed ID: 18280396
    [No Abstract]   [Full Text] [Related]  

  • 42. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
    Meiss F; Marsch WC; Fischer M
    Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct pattern of direct immunofluorescence in livedoid vasculopathy.
    Hsiao PF; Wu YH
    Am J Dermatopathol; 2010 May; 32(3):240-243. PubMed ID: 20075710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.
    James AH; Brancazio LR; Gehrig TR; Wang A; Ortel TL
    J Matern Fetal Neonatal Med; 2006 Sep; 19(9):543-9. PubMed ID: 16966122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol.
    Wakelin SH; Ellis JP; Black MM
    Br J Dermatol; 1998 Nov; 139(5):935-7. PubMed ID: 9892980
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anticoagulation using low-molecular-weight heparin--interview with Regina Burian].
    Hartmann A
    Hamostaseologie; 2005 Nov; 25(4):405-6. PubMed ID: 16402488
    [No Abstract]   [Full Text] [Related]  

  • 47. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links.
    Mousa SA
    Semin Thromb Hemost; 2007 Jul; 33(5):524-33. PubMed ID: 17629850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ["Idiopathic" white atrophy].
    Tran MD; Bécherel PA; Cordel N; Piette JC; Francès C
    Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1003-7. PubMed ID: 11907958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy.
    Zeni P; Finger E; Scheinberg MA
    Ann Rheum Dis; 2008 Jul; 67(7):1055-6. PubMed ID: 18556452
    [No Abstract]   [Full Text] [Related]  

  • 50. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation.
    Bhagirath KM; Tam JW
    Ann Thorac Surg; 2007 Dec; 84(6):2110-2. PubMed ID: 18036954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
    Ozkan M; Eser B; Er O; Dogu GG; Altinbas M
    J Clin Oncol; 2005 Mar; 23(9):2113; author reply 2113-4. PubMed ID: 15774812
    [No Abstract]   [Full Text] [Related]  

  • 52. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
    Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
    An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of low molecular weight heparin in women with recurrent pregnancy loss].
    Todorova K; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():31-6. PubMed ID: 15673011
    [No Abstract]   [Full Text] [Related]  

  • 54. Best evidence topic report. Low molecular weight heparin for intravenous drug users with deep vein thrombosis.
    Russell M; Dawson D
    Emerg Med J; 2004 Nov; 21(6):711. PubMed ID: 15496703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Livedo reticularis and livedoid vasculitis responding to PUVA therapy.
    Choi HJ; Hann SK
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):204-7. PubMed ID: 10025746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.
    Meuris B; Arnout J; Vlasselaers D; Schetz M; Meyns B
    Artif Organs; 2007 May; 31(5):402-5. PubMed ID: 17470211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Low-molecular weight heparin in the treatment of pregnant women with high thrombotic risk].
    Todorova K; Mazneĭkova V; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43(4):46-52. PubMed ID: 15318544
    [No Abstract]   [Full Text] [Related]  

  • 60. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.